Maravai LifeSciences Holdings, Inc. (MRVI) Operating cash flow 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$57.6MFY2025 · since FY2019: $24.1M → -$57.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.6M | -871.2% |
| FY2024 | $7.5M | -94.1% |
| FY2023 | $126.2M | -76.4% |
| FY2022 | $536.0M | +45.4% |
| FY2021 | $368.6M | +142.2% |
| FY2020 | $152.2M | +531.1% |
| FY2019 | $24.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net incomeMRVI Net marginMRVI Gross profitMRVI Gross marginMRVI Operating incomeMRVI Operating marginMRVI Free cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Total liabilitiesMRVI Shareholders’ equityMRVI overview →